LLY vs NVO
Eli Lilly and Company · Novo Nordisk A/S
Relative return (rebased to 100)
Key stats
| Metric | LLY | NVO |
|---|---|---|
| Price | $1,210.02 | $51.58 |
| Market Cap | $1.14T | $229.22B |
| P/E | 55.21 | — |
| P/B | 36.53 | — |
| P/S | 17.48 | — |
| ROE | 66.2% | — |
| Net Margin | 31.7% | — |
| Gross Margin | — | — |
| Revenue Growth | 44.7% | — |
| Dividend Yield | 0.51% | — |
| EPS | $21.92 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.